| 查看: 382 | 回复: 0 | |||
liruihan铁杆木虫 (正式写手)
|
[交流]
【转帖】导管原位癌治疗的比较效应及边缘和外科医生的影响
|
|
Comparative Effectiveness of Ductal Carcinoma In Situ Management and the Roles of Margins and Surgeons. Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, Stark A, Griggs JJ. J Natl Cancer Inst. 2011 Jan 3. [Epub ahead of print] http://jnci.oxfordjournals.org/c ... 1/01/03/jnci.djq499 Background The high incidence of ductal carcinoma in situ (DCIS) and variations in its treatment motivate inquiry into the comparative effectiveness of treatment options. Few such comparative effectiveness studies of DCIS, however, have been performed with detailed information on clinical and treatment attributes. Methods We collected detailed clinical, nonclinical, pathological, treatment, and long-term outcomes data from multiple medical records of 994 women who were diagnosed with DCIS from 1985 through 2000 in Monroe County (New York) and the Henry Ford Health System (Detroit, MI). We used ipsilateral disease-free survival models to characterize the role of treatments (surgery and radiation therapy) and margin status (positive, close [<2 mm], or negative [≥2 mm]) and logistic regression models to characterize the determinants of treatments and margin status, including the role of surgeons. All statistical tests were two-sided. Results Treatments and margin status were statistically significant and strong predictors of long-term disease-free survival, but results varied substantially by surgeon. This variation by surgeon accounted for 15%-35% of subsequent ipsilateral 5-year recurrence rates and for 13%-30% of 10-year recurrence rates. The overall differences in predicted 5-year disease-free survival rates for mastectomy (0.993), breast-conserving surgery with radiation therapy (0.945), and breast-conserving surgery without radiation therapy (0.824) were statistically significant (P(diff) < .001 for each of the differences). Similarly, each of the differences at 10 years was statistically significant (P < .001). Conclusions Our work demonstrates the contributions of treatments and margin status to long-term ipsilateral disease-free survival and the link between surgeons and these key measures of care. Although variation by surgeon could be generated by patients' preferences, the extent of variation and its contribution to long-term health outcomes are troubling. Further work is required to determine why women with positive margins receive no additional treatment and why margin status and receipt of radiation therapy vary by surgeon |
回复此楼» 猜你喜欢
生物信息学或者生物相关专业 （学硕）
已经有0人回复
-
凉了，国合查不到。
已经有12人回复
-
眼科学论文润色/翻译怎么收费?
已经有247人回复
-
药物递送/纳米药物/生物医用高分子材料/免疫治疗 | 北欧招聘博士生
已经有4人回复
-
求导师推荐 夏令营提前联系导师
已经有0人回复
-
本科浙大临床医学317求调剂
已经有5人回复
-
美国肯塔基大学Dr. Sheng Tong博士后招聘（空间可控的基因组编辑与肿瘤免疫治疗）
已经有115人回复